These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22916563)

  • 1. [Chronic active Epstein-Barr virus infection].
    Kimura H
    Uirusu; 2011 Dec; 61(2):163-73. PubMed ID: 22916563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
    Kimura H
    Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic Epstein-Barr virus infection].
    Imashuku S; Teramura T
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():503-7. PubMed ID: 15861702
    [No Abstract]   [Full Text] [Related]  

  • 5. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
    Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection.
    Kimura H; Hoshino Y; Hara S; Sugaya N; Kawada J; Shibata Y; Kojima S; Nagasaka T; Kuzushima K; Morishima T
    J Infect Dis; 2005 Feb; 191(4):531-9. PubMed ID: 15655776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Concise Viewpoints of Chronic Active Epstein-Barr Virus Infection.
    Okano M
    Curr Pediatr Rev; 2015; 11(1):5-9. PubMed ID: 25938379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis.
    Xiao H; Hu B; Luo R; Hu H; Zhang J; Kuang W; Zhang R; Li L; Liu G
    Virol J; 2020 Oct; 17(1):166. PubMed ID: 33121509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
    Kasahara Y; Yachie A; Takei K; Kanegane C; Okada K; Ohta K; Seki H; Igarashi N; Maruhashi K; Katayama K; Katoh E; Terao G; Sakiyama Y; Koizumi S
    Blood; 2001 Sep; 98(6):1882-8. PubMed ID: 11535525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.
    Imadome K; Yajima M; Arai A; Nakazawa A; Kawano F; Ichikawa S; Shimizu N; Yamamoto N; Morio T; Ohga S; Nakamura H; Ito M; Miura O; Komano J; Fujiwara S
    PLoS Pathog; 2011 Oct; 7(10):e1002326. PubMed ID: 22028658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
    Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
    J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features of adult-onset chronic active Epstein-Barr virus infection].
    Kawamoto K; Miyoshi H; Seto M; Kimura H; Ohshima K
    Rinsho Ketsueki; 2019; 60(8):944-952. PubMed ID: 31484894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients With Natural Killer (NK) Cell Chronic Active Epstein-Barr Virus Have Immature NK Cells and Hyperactivation of PI3K/Akt/mTOR and STAT1 Pathways.
    Howe MK; Dowdell K; Kuehn HS; Li Q; Hart GT; Garabedian D; Liepshutz K; Hsu AP; Su H; Niemela JE; Stoddard JL; Uzel G; Shereck E; Schulz L; Feldman T; Rosenzweig SD; Long EO; Dropulic L; Cohen JI
    J Infect Dis; 2020 Sep; 222(7):1170-1179. PubMed ID: 32386415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK-cell post-transplant lymphoproliferative disease with chronic active Epstein-Barr virus infection-like clinical findings.
    Iemura T; Kondo T; Hishizawa M; Yamashita K; Kimura H; Takaori-Kondo A
    Int J Infect Dis; 2019 Nov; 88():31-33. PubMed ID: 31398454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of Epstein-Barr virus DNA is helpful for evaluation of chronic active Epstein-Barr virus infection.
    Sakamoto Y; Mariya Y; Kubo K
    Tohoku J Exp Med; 2012 Aug; 227(4):307-11. PubMed ID: 22850617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced-intensity SCT for chronic active EBV infection: excellent outcomes should trigger future investigations on how EBV-positive recipient cells are eradicated.
    Gottschalk S
    Bone Marrow Transplant; 2011 Jan; 46(1):18-9. PubMed ID: 20956953
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
    Cohen JI; Jaffe ES; Dale JK; Pittaluga S; Heslop HE; Rooney CM; Gottschalk S; Bollard CM; Rao VK; Marques A; Burbelo PD; Turk SP; Fulton R; Wayne AS; Little RF; Cairo MS; El-Mallawany NK; Fowler D; Sportes C; Bishop MR; Wilson W; Straus SE
    Blood; 2011 Jun; 117(22):5835-49. PubMed ID: 21454450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
    Kasahara Y; Yachie A
    Crit Rev Oncol Hematol; 2002 Dec; 44(3):283-94. PubMed ID: 12467968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated guidelines for chronic active Epstein-Barr virus disease.
    Kawada JI; Ito Y; Ohshima K; Yamada M; Kataoka S; Muramatsu H; Sawada A; Wada T; Imadome KI; Arai A; Iwatsuki K; Ohga S; Kimura H;
    Int J Hematol; 2023 Nov; 118(5):568-576. PubMed ID: 37728704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.